Press releases
- GSK delivers strong Q2 sales of £8.1 billion, +6% AER, +15% CER Total EPS 27.9p -39% AER, -28% CER; Adjusted EPS 28.1p +46% AER +71% CER
- Shingrix approved in the US for prevention of shingles in immunocompromised adults
- GSK begins shipping another record supply of influenza vaccine for 2021-22 season in US
Tweets from GSK US
-
GSKUS @GSKUS
Stan, a patient spokesperson for GSK, was 66 and in the best shape of his life when he contracted #hepatitis A at a restaurant in 2017. #WorldHepatitisDay is today and a good opportunity to discuss #hepA vaccination with your doctor! #WHDRelay @Hep_Alliance
about 7 hours ago -
GSKUS @GSKUS
Hepatitis A is a highly infectious, vaccine-preventable liver infection. As a patient & spokesperson for GSK, Angela learned, anyone can be at risk for #Hepatitis A. On #WorldHepatitisDay, talk to your doctor about #HepA vaccination. gsk.to/3f6t7Pu @Hep_Alliance
about 7 hours ago
-
GSKUS @GSKUS
We must improve #cancercare to better support people with cancer and their unique needs. Our very own Michael Petroutsas, SVP, US Oncology Business Unit Head, discusses alongside @shannonmiller96 & @ZainabSalbi, presented by GSK. #cancercare #PostLive twitter.com/PostLive/statu…
about 11 hours ago
